跳至主要内容
临床试验/NCT02203266
NCT02203266已完成不适用

A Randomised, Parallel-group, Multi-centre Trial Using a Novel INCA Tracker Device to Measure and Monitor Compliance and Technique of Seretide Diskus Inhaler in a Community Pharmacy Setting

Beaumont Hospital1 个研究点 分布在 1 个国家目标入组 152 人开始时间: 2014年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
152
试验地点
1
主要终点
Rate of adherence

研究概览

简要总结

The purpose of this trial is to discover whether providing feedback to patients from a device that records when and how well a patient uses a Seretide Diskus inhaler will lead to:

  • Improved compliance with prescribed inhaler use
  • Improved technique of inhaler use
  • A reduction in respiratory health related outcomes caused by poor inhaler compliance and usage.
  • An improvement in patient quality of life scores

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Must be 18 years old or above
  • Capable of understanding and willing to provide voluntary informed consent before any protocol specific procedures are performed
  • Capable of understanding and complying with the requirements of the protocol, and demonstrating a willingness to attend for all required visits.
  • Able and willing to take inhaled medication.
  • Have a valid prescription for use of a Seretide diskus inhaler or already using a Seretide diskus inhaler.
  • Have a history of regular attendance in the pharmacy in which they are recruited which will be demonstrated by the subject having collected three prescriptions for any medication in that pharmacy in the six months preceeding their recruitment to the study.

排除标准

  • Patient expressly reports that their physician has indicated that they will not be continuing to receive Seretide over the next 6 months

研究组 & 干预措施

Feedback

Experimental

Feedback on the patient's own inhaler use, with personalized information on the patients technique and timing of use of the diskus inhaler as recorded on the INCA device will be provided to patients in the feedback group after 1,2 and 6 months.

干预措施: Feedback (Device)

Demonstration

Active Comparator

Current best practice - inhaler technique education

干预措施: Education (Behavioral)

Control

No Intervention

Usual care in the community pharmacy setting

结局指标

主要结局

Rate of adherence

时间窗: 2 months and 6 months

The rate of adherence is the proportion of correctly taken drugs at the correct time relative to the prescribed interval.

次要结局

  • Rescue antibiotic and/or steroid medication use(6 months)
  • Adherence in the time domain(Two months and six months)
  • Rescue inhaled medication use(Six months)
  • Quality of life(2 months and 6 months)
  • Technique adherence(Two months and six months)

研究者

发起方
Beaumont Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Professor Richard Costello

Professor Richard Costello

Beaumont Hospital

研究点 (1)

Loading locations...

相似试验